A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

660

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2030

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Livmoniplimab

Intravenous (IV) Solution

DRUG

Budigalimab

Intravenous (IV) Solution

DRUG

Durvalumab

Intravenous (IV) Solution

DRUG

Atezolizumab

Intravenous (IV) Solution

DRUG

Bevacizumab

Intravenous (IV) Solution

DRUG

Tremelimumab

Intravenous (IV) Solution

Trial Locations (37)

100

RECRUITING

National Taiwan University Hospital /ID# 256168, Taipei City

704

RECRUITING

National Cheng Kung University Hospital /ID# 256766, Tainan City

11217

RECRUITING

Taipei Veterans General Hosp /ID# 256169, Taipei

14004

RECRUITING

Hospital Universitario Reina Sofia /ID# 255779, Córdoba

20089

RECRUITING

IRCCS Istituto Clinico Humanitas /ID# 256684, Rozzano

20132

RECRUITING

IRCCS Ospedale San Raffaele /ID# 256404, Milan

28007

RECRUITING

Hospital General Universitario Gregorio Maranon /ID# 255772, Madrid

28222

RECRUITING

Hospital Universitario Puerta de Hierro - Majadahonda /ID# 255778, Majadahonda

38700

RECRUITING

CHU Grenoble - Hopital Michallon /ID# 256627, La Tronche

39008

RECRUITING

Hospital Universitario Marques de Valdecilla /ID# 255769, Santander

40138

RECRUITING

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 256412, Bologna

40447

ACTIVE_NOT_RECRUITING

China Medical University Hospital /ID# 256764, Taichung

40705

ACTIVE_NOT_RECRUITING

Taichung Veterans General Hospital /ID# 259405, Taichung

41013

RECRUITING

Hospital Universitario Virgen del Rocio /ID# 255776, Seville

48202

RECRUITING

Henry Ford Hospital /ID# 255803, Detroit

50009

RECRUITING

Hospital Universitario Miguel Servet /ID# 255774, Zaragoza

55416

RECRUITING

Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 256041, Saint Louis Park

63110

RECRUITING

Washington University-School of Medicine /ID# 255720, St Louis

66204

COMPLETED

Alliance for Multispecialty Research LLC Kansas City Oncology /ID# 256830, Merriam

75246

RECRUITING

Texas Oncology - Dallas - Worth Street /ID# 265806, Dallas

79606

RECRUITING

Texas Oncology - Abilene - Antilley Road /ID# 265820, Abilene

80147

RECRUITING

P.O. Ospedale del Mare /ID# 256410, Naples

90127

RECRUITING

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone /ID# 256681, Palermo

91010

RECRUITING

City of Hope /ID# 261468, Duarte

92110

RECRUITING

Hopital Beaujon /ID# 256551, Clichy

92618

RECRUITING

City of Hope at Orange County Lennar Foundation Cancer Center /ID# 261669, Irvine

92868

RECRUITING

UC Irvine /ID# 255673, Orange

93000

RECRUITING

Hôpital Avicenne /ID# 266005, Bobigny

94805

RECRUITING

Institut Gustave Roussy /ID# 258460, Villejuif

98684

RECRUITING

Oncology and Hematology Associates of Southwest Virginia /ID# 265834, Roanoke

60637-1443

RECRUITING

The University of Chicago Medical Center /ID# 255674, Chicago

40217-1395

RECRUITING

Norton Cancer Institute /ID# 260775, Louisville

76508-0001

RECRUITING

Baylor Scott and White Research Institute /ID# 260853, Dallas

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 265506, Rome

00128

RECRUITING

Fondazione Policlinico Universitario Campus Bio-Medico /ID# 256895, Roma

00917

RECRUITING

Puerto Rico Medical Research Center /ID# 262362, Hato Rey

08035

RECRUITING

Hospital Universitario Vall d'Hebron /ID# 255771, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY